Antiglycolipid antibodies in motor neuropathies

Nicole Baumann, Marie Luce Harpin, Yannick Marie, Karine Lemerle, Benedicte Chassande, Pierre Bouche, Vincent Meininger, Robert K Yu, Jean Marc Léger

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In peripheral neuropathies with monoclonal gammopathy, mainly IgM, it appears clear from clinical, electrophysiological, and experimental data, that the target glycolipid or glycolipid epitope for the IgM is related to the type of neuropathy - purely sensory, predominantly sensory, or uniquely motor. Investigations have focused on chronic peripheral neuropathies associated with polyclonal IgM reactivity to glycolipids. Although IgM anti-GM1 antibodies are present in normal controls, there is a subgroup of motor neuropathies with high titer anti-GM1 antibodies, mainly multifocal neuropathies with conduction blocks (MMNCB). Another subgroup of MMNCB may include IgM anti-SGPG antibodies that do not cross-react with MAG. The importance of the fine structure of the epitope has to be considered in view of the pathogenicity of the antibody. It may bear consequences on its binding properties on the neuronal surfaces and on its biological implications.

Original languageEnglish (US)
Pages (from-to)322-329
Number of pages8
JournalAnnals of the New York Academy of Sciences
Volume845
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Immunoglobulin M
Glycolipids
Antibodies
Anti-Idiotypic Antibodies
Epitopes
Peripheral Nervous System Diseases
Paraproteinemias
Virulence
anti-IgM
Fine Structure
Reactivity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Baumann, N., Harpin, M. L., Marie, Y., Lemerle, K., Chassande, B., Bouche, P., ... Léger, J. M. (1998). Antiglycolipid antibodies in motor neuropathies. Annals of the New York Academy of Sciences, 845, 322-329. https://doi.org/10.1111/j.1749-6632.1998.tb09684.x

Antiglycolipid antibodies in motor neuropathies. / Baumann, Nicole; Harpin, Marie Luce; Marie, Yannick; Lemerle, Karine; Chassande, Benedicte; Bouche, Pierre; Meininger, Vincent; Yu, Robert K; Léger, Jean Marc.

In: Annals of the New York Academy of Sciences, Vol. 845, 01.01.1998, p. 322-329.

Research output: Contribution to journalArticle

Baumann, N, Harpin, ML, Marie, Y, Lemerle, K, Chassande, B, Bouche, P, Meininger, V, Yu, RK & Léger, JM 1998, 'Antiglycolipid antibodies in motor neuropathies', Annals of the New York Academy of Sciences, vol. 845, pp. 322-329. https://doi.org/10.1111/j.1749-6632.1998.tb09684.x
Baumann N, Harpin ML, Marie Y, Lemerle K, Chassande B, Bouche P et al. Antiglycolipid antibodies in motor neuropathies. Annals of the New York Academy of Sciences. 1998 Jan 1;845:322-329. https://doi.org/10.1111/j.1749-6632.1998.tb09684.x
Baumann, Nicole ; Harpin, Marie Luce ; Marie, Yannick ; Lemerle, Karine ; Chassande, Benedicte ; Bouche, Pierre ; Meininger, Vincent ; Yu, Robert K ; Léger, Jean Marc. / Antiglycolipid antibodies in motor neuropathies. In: Annals of the New York Academy of Sciences. 1998 ; Vol. 845. pp. 322-329.
@article{1d83ea5fd63142bbbb70747208ae8d5a,
title = "Antiglycolipid antibodies in motor neuropathies",
abstract = "In peripheral neuropathies with monoclonal gammopathy, mainly IgM, it appears clear from clinical, electrophysiological, and experimental data, that the target glycolipid or glycolipid epitope for the IgM is related to the type of neuropathy - purely sensory, predominantly sensory, or uniquely motor. Investigations have focused on chronic peripheral neuropathies associated with polyclonal IgM reactivity to glycolipids. Although IgM anti-GM1 antibodies are present in normal controls, there is a subgroup of motor neuropathies with high titer anti-GM1 antibodies, mainly multifocal neuropathies with conduction blocks (MMNCB). Another subgroup of MMNCB may include IgM anti-SGPG antibodies that do not cross-react with MAG. The importance of the fine structure of the epitope has to be considered in view of the pathogenicity of the antibody. It may bear consequences on its binding properties on the neuronal surfaces and on its biological implications.",
author = "Nicole Baumann and Harpin, {Marie Luce} and Yannick Marie and Karine Lemerle and Benedicte Chassande and Pierre Bouche and Vincent Meininger and Yu, {Robert K} and L{\'e}ger, {Jean Marc}",
year = "1998",
month = "1",
day = "1",
doi = "10.1111/j.1749-6632.1998.tb09684.x",
language = "English (US)",
volume = "845",
pages = "322--329",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Antiglycolipid antibodies in motor neuropathies

AU - Baumann, Nicole

AU - Harpin, Marie Luce

AU - Marie, Yannick

AU - Lemerle, Karine

AU - Chassande, Benedicte

AU - Bouche, Pierre

AU - Meininger, Vincent

AU - Yu, Robert K

AU - Léger, Jean Marc

PY - 1998/1/1

Y1 - 1998/1/1

N2 - In peripheral neuropathies with monoclonal gammopathy, mainly IgM, it appears clear from clinical, electrophysiological, and experimental data, that the target glycolipid or glycolipid epitope for the IgM is related to the type of neuropathy - purely sensory, predominantly sensory, or uniquely motor. Investigations have focused on chronic peripheral neuropathies associated with polyclonal IgM reactivity to glycolipids. Although IgM anti-GM1 antibodies are present in normal controls, there is a subgroup of motor neuropathies with high titer anti-GM1 antibodies, mainly multifocal neuropathies with conduction blocks (MMNCB). Another subgroup of MMNCB may include IgM anti-SGPG antibodies that do not cross-react with MAG. The importance of the fine structure of the epitope has to be considered in view of the pathogenicity of the antibody. It may bear consequences on its binding properties on the neuronal surfaces and on its biological implications.

AB - In peripheral neuropathies with monoclonal gammopathy, mainly IgM, it appears clear from clinical, electrophysiological, and experimental data, that the target glycolipid or glycolipid epitope for the IgM is related to the type of neuropathy - purely sensory, predominantly sensory, or uniquely motor. Investigations have focused on chronic peripheral neuropathies associated with polyclonal IgM reactivity to glycolipids. Although IgM anti-GM1 antibodies are present in normal controls, there is a subgroup of motor neuropathies with high titer anti-GM1 antibodies, mainly multifocal neuropathies with conduction blocks (MMNCB). Another subgroup of MMNCB may include IgM anti-SGPG antibodies that do not cross-react with MAG. The importance of the fine structure of the epitope has to be considered in view of the pathogenicity of the antibody. It may bear consequences on its binding properties on the neuronal surfaces and on its biological implications.

UR - http://www.scopus.com/inward/record.url?scp=0031928621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031928621&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1998.tb09684.x

DO - 10.1111/j.1749-6632.1998.tb09684.x

M3 - Article

VL - 845

SP - 322

EP - 329

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -